(Q36278355)

13 August 2017

Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

13 August 2017

1 reference

1 reference

Rina Mina

1

1 reference

13 August 2017

Emily von Scheven

2

1 reference

13 August 2017

Stacy P Ardoin

3

1 reference

13 August 2017

B Anne Eberhard

4

1 reference

13 August 2017

Marilynn Punaro

5

1 reference

13 August 2017

Norman Ilowite

6

1 reference

13 August 2017

Joyce Hsu

7

1 reference

13 August 2017

Marisa Klein-Gitelman

8

1 reference

13 August 2017

L Nandini Moorthy

9

1 reference

13 August 2017

Eyal Muscal

10

1 reference

13 August 2017

Suhas M Radhakrishna

11

1 reference

13 August 2017

Linda Wagner-Weiner

12

1 reference

13 August 2017

Matthew Adams

13

1 reference

13 August 2017

Peter Blier

14

1 reference

13 August 2017

Lenore Buckley

15

1 reference

13 August 2017

Elizabeth Chalom

16

1 reference

13 August 2017

Gaëlle Chédeville

17

1 reference

13 August 2017

Andrew Eichenfield

18

1 reference

13 August 2017

Natalya Fish

19

1 reference

13 August 2017

Michael Henrickson

20

1 reference

13 August 2017

Aimee O Hersh

21

1 reference

13 August 2017

Roger Hollister

22

1 reference

13 August 2017

Olcay Jones

23

1 reference

13 August 2017

Lawrence Jung

24

1 reference

13 August 2017

Deborah Levy

25

1 reference

13 August 2017

Jorge Lopez-Benitez

26

1 reference

13 August 2017

Deborah McCurdy

27

1 reference

13 August 2017

Paivi M Miettunen

28

1 reference

13 August 2017

Ana I Quintero-del Rio

29

1 reference

13 August 2017

Deborah Rothman

30

1 reference

13 August 2017

Ornella Rullo

31

1 reference

13 August 2017

Natasha Ruth

32

1 reference

13 August 2017

Laura E Schanberg

33

1 reference

13 August 2017

Earl Silverman

34

1 reference

13 August 2017

Nora G Singer

35

1 reference

13 August 2017

Jennifer Soep

36

1 reference

13 August 2017

Reema Syed

37

1 reference

13 August 2017

Larry B Vogler

38

1 reference

13 August 2017

Ali Yalcindag

39

1 reference

13 August 2017

Cagri Yildirim-Toruner

40

1 reference

13 August 2017

Carol A Wallace

41

1 reference

13 August 2017

Hermine I Brunner

42

1 reference

13 August 2017

Carra SLE Subcommittee

43

1 reference

13 August 2017

1 March 2012

1 reference

Arthritis Care and Research

13 August 2017

1 reference

13 August 2017

64

1 reference

13 August 2017

3

1 reference

13 August 2017

375-383

1 reference

Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

European consensus statement on the terminology used in the management of lupus glomerulonephritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

The classification of glomerulonephritis in systemic lupus erythematosus revisited

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

The national glycohemoglobin standardization program: a five-year progress report.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Mycophenolate mofetil treatment in children and adolescents with lupus

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Clinical outcomes of childhood lupus nephritis: a single center's experience.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Clinicopathological correlations of paediatric lupus nephritis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Longterm followup of childhood lupus nephritis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Ensuring safety of patients receiving sedation for procedures: evaluation of clinical practice guidelines.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

The PedsQL: measurement model for the pediatric quality of life inventory

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3457803

Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis

22 September 2018

1 reference

12 December 2020

Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

1 reference

12 December 2020

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study

1 reference

12 December 2020

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial

1 reference

12 December 2020

Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy

1 reference

12 December 2020

The long-term outcome of 93 patients with proliferative lupus nephritis

1 reference

12 December 2020

Practice pattern variation in oral glucocorticoid therapy after the induction of response in proliferative lupus nephritis.

1 reference

12 December 2020

Identifiers

DOI

10.1002/ACR.21558

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22162255

1 reference